TSX/LABS (TSX/LABS)

Toronto Stock Exchange: TSX/LABS · CAD

CA$0.07

+0.00 (0.0%)· Recorded snapshot

Market cap	27.8M
Revenue (ttm)	41.5M
Net income (ttm)	-5M
EPS (ttm)	-CA$0.01
Shares out	427.2M
Volume	219,003
Beta	0.85

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 41.5M
Net income (ttm): -5M
EPS (ttm): -CA$0.01
Market cap: 27.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROE-13.2

P25 -104.1P50 -30P75 6.7

ROIC-15.7

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All TSX/LABS indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

CAD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-13
Employees	127
Employees change	-34
Employees growth	-21.12%
Enterprise value	CAD 17.8M
Exchange	Toronto Stock Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2015
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA58504D1006
Last earnings date	2026-08-13
Last refreshed	2026-10-29
Market cap	CAD 27.8M
Next earnings date	2026-11-13
Price	CAD 0.07
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	tsx/LABS
Website	https://www.medipharmlabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-18.08%
EV/Sales	0.43x
FCF / EV yield	-5.88%
FCF yield	-3.76%
Industry forward P/E	34.4x
P/B ratio	0.78x
P/S ratio	0.67x
Price / tangible book value	0.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-9.51%
EBITDA margin	-5.82%
Gross margin	31.7%
Operating margin	-9.51%
Pretax margin	-12%
Profit margin	-12%
Profit per employee	CAD -39,157
Profitable quarters	1
Revenue per employee	CAD 326,433
ROA	-5.17%
ROA (5Y)	-16.32%
ROCE	-11.13%
ROE	-13.22%
ROE (5Y)	-35.62%
ROIC	-15.7%
ROIC (5Y)	-47.43%
SBC / revenue	2.41%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	5
Gross profit growth	-10.47%
Gross profit growth (Q)	15.25%
Gross profit growth 3Y	373.25%
Net income growth quarters	1
Net income growth years	5
Revenue growth	-6.74%
Revenue growth (Q)	-15.45%
Revenue growth (QoQ)	11.39%
Revenue growth 3Y	13.57%
Revenue growth 5Y	13.96%
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -63,000
Depreciation and amortization	CAD 1.5M
EBIT	CAD -3.9M
EBITDA	CAD -2.4M
EPS	CAD -0.01
FCF per share	CAD -0.00
Financing cash flow	CAD 47,000
Free cash flow	CAD -1M
Free cash flow minus SBC	CAD -2M
Gross profit	CAD 13.1M
Investing cash flow	CAD 412,000
Net borrowing	CAD -124,000
Net cash flow	CAD -512,000
Net income	CAD -5M
Operating cash flow minus SBC	CAD -2M
Operating income	CAD -3.9M
Revenue	CAD 41.5M
Stock-based compensation	CAD 999,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-2.38
Book value per share	CAD 0.08
Debt / equity	0.01
Interest coverage	-63.58
Long-term assets	CAD 17.6M
Long-term liabilities	CAD 0
Net cash (debt)	CAD 10M
Net cash / market cap	36.01%
Net cash growth	-1.01%
Net debt / equity	-0.28
Piotroski F-Score	2
Property, plant and equipment	CAD 17M
Shareholders' equity	CAD 35.4M
Tangible book value	CAD 34.8M
Tangible book value per share	CAD 0.08
Total assets	CAD 46M
Total cash	CAD 10.4M
Total debt	CAD 421,000
Total liabilities	CAD 10.6M
WACC	8.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.87
Current assets	CAD 28.4M
Current liabilities	CAD 10.6M
Current ratio	2.69
Inventory turnover	3.01
Net working capital	CAD 7.9M
Quick ratio	1.68
Working capital	CAD 17.9M
Working capital turnover	2.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.31%
Shareholder yield	-2.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.07
1D price change	0%
1M price change	-7.14%
1M total return	-7.14%
1Y price change	-13.33%
1Y return CAGR	-13.34%
1Y total return	-13.33%
20-day SMA	CAD 0.07
200-day SMA	CAD 0.07
3M price change	-13.33%
3M total return	-13.33%
3Y price change	-13.33%
3Y return CAGR	-4.66%
3Y total return	-13.33%
50-day SMA	CAD 0.07
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.10
52-week high date	2026-04-28
52-week low	CAD 0.06
52-week low date	2026-10-26
5Y price change	-75%
5Y return CAGR	-24.22%
5Y total return	-75%
6M price change	-27.78%
6M total return	-27.78%
All-time high	CAD 7.39
All-time high date	2019-05-14
All-time low	CAD 0.06
All-time low date	2023-06-27
Average true range (ATR)	CAD 0.00
Average volume	119.9K
Beta (1Y)	0.57
Beta (2Y)	0.75
Beta (5Y)	0.85
Change from 52-week high	-35%
Change from 52-week low	8.33%
Change from all-time high	-99.12%
Change from all-time low	18.18%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 14,235
High price	CAD 0.07
Low price	CAD 0.07
Monthly RSI	42.51
Open price	CAD 0.07
Previous close	CAD 0.07
Price vs 150-day SMA	-11.44%
Price vs 20-day SMA	-2.26%
Price vs 200-day SMA	-9.85%
Price vs 50-day SMA	-8.32%
Relative volume	1.83
RSI	43.3
Sharpe ratio	0.14
Sharpe ratio (3Y)	0.31
Sharpe ratio (5Y)	0.04
Sortino ratio	0.3
Sortino ratio (3Y)	0.56
Sortino ratio (5Y)	0.14
Volume	219K
Weekly RSI	38.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	390M
Shares change (QoQ)	0.16%
Shares change (YoY)	2.31%
Shares held by insiders	8.7%
Shares held by institutions	0%
Shares outstanding	427.2M

Deeper analysis on TSX/LABS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/LABS report

Is a complete TSX/LABS research report available?

No complete published report is available for tsx/LABS (TSX/LABS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/LABS (TSX/LABS)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/LABS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/LABS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/LABS

Frequently asked questions